Rose; Peter Robert

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rose; Peter Robert.The latest application filed is for "pyrrolo[2,3-d]pyrimidine tosylate salt, crystalline form thereof and manufacturing process and intermediates thereto".

Company Profile

0.3.13

Rose; Peter Robert - Uncasville CT
Rose; Peter Robert - Ledyard CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Crystalline form of lorlatinib free base hydrate Grant 11,299,500 - Bowles , et al. April 12, 2	2022-04-12
Pyrrolo[2,3-d]pyrimidine Tosylate Salt, Crystalline Form Thereof And Manufacturing Process And Intermediates Thereto App 20210387989 - SAMAS; Brian Matthew ; et al.	2021-12-16
Crystalline Form Of Lorlatinib Free Base Hydrate App 20200308191 - Bowles; Paul ; et al.	2020-10-01
Novel Forms of [R-(R,R)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)carbonyl]-1H-P- yrrole-1-Heptanoic Acid Calcium Salt (2:1) App 20180009748 - Krzyzaniak; Joseph Francis ; et al.	2018-01-11
Novel Forms of [R-(R,R)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)carbonyl]-1H-P- yrrole-1-Heptanoic Acid Calcium Salt (2:1) App 20170022156 - Krzyzaniak; Joseph Francis ; et al.	2017-01-26
Novel Forms of [R-(R,R)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)carbonyl]-1H-P- yrrole-1-Heptanoic Acid Calcium Salt (2:1) App 20160046575 - Krzyzaniak; Joseph Francis ; et al.	2016-02-18
Process for forming amorphous atorvastatin Grant 9,056,831 - deBettencourt, III , et al. June 16, 2	2015-06-16
Novel Forms of [R-(R,R)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)carbonyl]-1H-P- yrrole-1-Heptanoic Acid Calcium Salt (2:1) App 20150045563 - Krzyzaniak; Joseph Francis ; et al.	2015-02-12
Process for Forming Amorphous Atorvastatin App 20140155627 - deBettencourt, III; Antone John ; et al.	2014-06-05
Novel Forms of [R-(R,R)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)carbonyl]-1H-P- yrrole-1-Heptanoic Acid Calcium Salt (2:1) App 20140018546 - Krzyzaniak; Joseph Francis ; et al.	2014-01-16
Process for Forming Amorphous Atorvastatin App 20080269314 - Debetten-Court; Antone John ; et al.	2008-10-30
Process for the preparation of 1,3-substituted indenes Grant 7,285,686 - Handfield, Jr. , et al. October 23, 2	2007-10-23
Process for Forming Amorphous Atorvastatin App 20070225353 - Leonard; Jason Albert ; et al.	2007-09-27
Complexes of E-2-Methoxy-N-(3-{4-[3-methyl-4-(6-methyl-pyridin-3-yloxy)-ph- enylamino]-quinazolin-6-yl}-allyl)-acetamide and methods of preparing same App 20050272752 - Johnson, Phillip James ; et al.	2005-12-08
Process for the preparation of 1,3-substituted indenes App 20050004379 - Handfield, Robert Eugene JR. ; et al.	2005-01-06
Recipe recorder for automated chemistry App 20030222905 - Wierenga, Craig R. ; et al.	2003-12-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.